Suppr超能文献

法布里病成人期的心电图变化:一项大型纵向队列研究的结果

ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study.

作者信息

El Sayed Mohamed, Postema Pieter G, Datema Mareen, van Dussen Laura, Kors Jan A, Ter Haar Cato C, Bleijendaal Hidde, Galenkamp Henrike, van den Born Bert-Jan H, Hollak Carla E M, Langeveld Mirjam

机构信息

Department of Internal Medicine, Division of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Amsterdam Gastroenterology Endocrinology and Metabolism, Inborn Errors of Metabolism, 1105 AZ Amsterdam, The Netherlands.

出版信息

Diagnostics (Basel). 2023 Jan 18;13(3):354. doi: 10.3390/diagnostics13030354.

Abstract

Fabry disease (FD) is an X-linked, lysosomal storage disorder leading to severe cardiomyopathy in a significant proportion of patients. To identify ECG markers that reflect early cardiac involvement and disease progression, we conducted a long term retrospective study in a large cohort of FD patients. A total of 1995 ECGs from 133 patients with classical FD (64% females, 80% treated with enzyme replacement therapy), spanning 20 years of follow-up, were compared to ECGs from 3893 apparently healthy individuals. Generalized linear mixed models were used to evaluate the effect of age, FD and sex on: P-wave duration, PR-interval, QRS-duration, QTc, Cornell index, spatial QRS-T angle and frontal QRS-axis. Regression slopes and absolute values for each parameter were compared between FD patients and control subjects. At a younger age (<40 years), the Cornell index was higher and frontal QRS-axis more negative in FD patients compared to controls ( < 0.05). For the other ECG parameters, the rate of change, more than the absolute value, was greater in FD patients compared to controls ( < 0.05). From the fifth decade (men) or sixth (women) onwards, absolute values for P-wave duration, QRS-duration, QTc and spatial QRS-T angle were longer and higher in FD patients compared to control subjects. ECG abnormalities indicative of FD are age and sex dependent. Tracking the rate of change in ECG parameters could be a good way to detect disease progression, guiding treatment initiation. Moreover, monitoring ECG changes in FD can be used to evaluate the effectiveness of treatment.

摘要

法布里病(FD)是一种X连锁的溶酶体贮积症,在相当一部分患者中会导致严重的心肌病。为了确定反映早期心脏受累和疾病进展的心电图标志物,我们对一大群FD患者进行了一项长期回顾性研究。将133例经典型FD患者(64%为女性,80%接受酶替代疗法治疗)在20年随访期间的总共1995份心电图与3893名明显健康个体的心电图进行了比较。使用广义线性混合模型来评估年龄、FD和性别对以下指标的影响:P波时限、PR间期、QRS时限、QTc、康奈尔指数、空间QRS-T夹角和额面QRS轴。比较了FD患者和对照受试者之间每个参数的回归斜率和绝对值。在较年轻的年龄(<40岁),与对照组相比,FD患者的康奈尔指数更高,额面QRS轴更偏负(<0.05)。对于其他心电图参数,与对照组相比,FD患者的变化率(而非绝对值)更大(<0.05)。从第五个十年(男性)或第六个十年(女性)起,与对照受试者相比,FD患者的P波时限、QRS时限、QTc和空间QRS-T夹角的绝对值更长、更高。提示FD的心电图异常与年龄和性别有关。追踪心电图参数的变化率可能是检测疾病进展、指导开始治疗的好方法。此外,监测FD患者的心电图变化可用于评估治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c61e/9913957/8544f3f5580c/diagnostics-13-00354-g001.jpg

相似文献

1
ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study.
Diagnostics (Basel). 2023 Jan 18;13(3):354. doi: 10.3390/diagnostics13030354.
2
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
Heart. 2016 Aug 15;102(16):1309-14. doi: 10.1136/heartjnl-2015-308897. Epub 2016 Apr 7.
4
Characteristics of the Electrocardiogram in Japanese Fabry Patients Under Long-Term Enzyme Replacement Therapy.
Front Cardiovasc Med. 2021 Jan 14;7:614129. doi: 10.3389/fcvm.2020.614129. eCollection 2020.
5
Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy.
Am J Cardiol. 2022 Sep 1;178:131-136. doi: 10.1016/j.amjcard.2022.05.021. Epub 2022 Jul 6.
6
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement.
Int J Cardiol. 2021 Sep 15;339:110-117. doi: 10.1016/j.ijcard.2021.07.022. Epub 2021 Jul 16.
8
Progression of electrocardiogram changes in an untreated fabry disease: a case report.
Eur Heart J Case Rep. 2021 Feb 20;5(2):ytab045. doi: 10.1093/ehjcr/ytab045. eCollection 2021 Feb.
9
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101.
10
Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures.
Int J Cardiol. 2021 Sep 1;338:121-126. doi: 10.1016/j.ijcard.2021.06.032. Epub 2021 Jun 19.

引用本文的文献

1
A composite measurement concept for monitoring cardiac function in Fabry disease.
Orphanet J Rare Dis. 2025 Jul 28;20(1):382. doi: 10.1186/s13023-025-03895-x.
2
Cryo-ablation management of atrial fibrillation in Fabry disease without agalsidase alpha: a case report.
Front Cardiovasc Med. 2025 May 30;12:1483283. doi: 10.3389/fcvm.2025.1483283. eCollection 2025.
3
Applying artificial intelligence to rare diseases: a literature review highlighting lessons from Fabry disease.
Orphanet J Rare Dis. 2025 Apr 17;20(1):186. doi: 10.1186/s13023-025-03655-x.
4
2024 Update of the TSOC Expert Consensus of Fabry Disease.
Acta Cardiol Sin. 2024 Sep;40(5):544-568. doi: 10.6515/ACS.202409_40(5).20240731A.
5
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking.
Front Cardiovasc Med. 2023 Jun 21;10:1184361. doi: 10.3389/fcvm.2023.1184361. eCollection 2023.
6
Increased cardiac involvement in Fabry disease using blood-corrected native T1 mapping.
Sci Rep. 2023 Mar 17;13(1):4420. doi: 10.1038/s41598-023-31211-9.

本文引用的文献

2
Fabry Disease and the Heart: A Comprehensive Review.
Int J Mol Sci. 2021 Apr 23;22(9):4434. doi: 10.3390/ijms22094434.
3
Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease.
Heart. 2021 Dec;107(23):1889-1897. doi: 10.1136/heartjnl-2020-317922. Epub 2021 Feb 10.
4
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
Heart. 2022 Jan;108(1):54-60. doi: 10.1136/heartjnl-2020-318271. Epub 2021 Feb 9.
5
Characteristics of the Electrocardiogram in Japanese Fabry Patients Under Long-Term Enzyme Replacement Therapy.
Front Cardiovasc Med. 2021 Jan 14;7:614129. doi: 10.3389/fcvm.2020.614129. eCollection 2020.
6
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101.
10
Cardiac Phenotype of Prehypertrophic Fabry Disease.
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007168. doi: 10.1161/CIRCIMAGING.117.007168.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验